RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
VG Life Sciences Stock

VG Life Sciences Stocks 2024

VG Life Sciences Stocks

27.63 M

Ticker

VGLS

ISIN

US91822T1016

WKN

A1J8VF

In 2024, VG Life Sciences had 27.63 M outstanding stocks, a 237.41% change from the 8.19 M stocks in the previous year.

The VG Life Sciences Stocks history

YEARNUMBER OF STOCKS (undefined USD)
201427.63
20138.19
20122.15
20111.22
20100.92
20090.58
20080.28
20070.24
20060.17
20050.15
20040.1
20030.07
20020.06
20010.05
20000.05

VG Life Sciences shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue VG Life Sciences earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates VG Life Sciences's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of VG Life Sciences’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating VG Life Sciences's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

VG Life Sciences Aktienanalyse

What does VG Life Sciences do?

VG Life Sciences Inc is a California-based company that specializes in the research, development, and commercialization of new medical technologies and products. The company collaborates closely with researchers, academics, and professionals worldwide to develop and market innovative solutions for the healthcare industry. Its core business is the research and development of drugs based on plant substances and natural products. The company has developed a unique technology platform that allows for the selection of specific target molecules in the human body from thousands of natural compounds. These compounds are further studied and optimized to develop active ingredients for the treatment of various diseases. VG Life Sciences also has its own line of dietary supplements and skincare products based on natural ingredients. These products are available under the brand Vivid GLOW and are sold on online platforms and selected retail stores. The company also focuses on dietary supplements and uses its extensive medical expertise to develop high-quality products based on the latest research. These products are designed to promote overall health and enable a longer and more productive life. Another business area of VG Life Sciences is its laboratory services business. The company offers a wide range of services, from raw material analysis to drug formulation and clinical drug testing. It has significantly expanded its capabilities and now has a modern analysis and research laboratory equipped with the latest technological instruments and devices. The company also provides training and consulting services to support customers in the development and marketing of new medical products. VG Life Sciences is committed to ensuring high quality and scientific excellence in all business areas. To achieve this, the company has assembled a team of experienced researchers and scientists and collaborates with various academic and industry partners. It places great emphasis on compliance with standards and regulations and works closely with relevant authorities to ensure that its products and services meet the highest standards. Overall, VG Life Sciences Inc is an innovative and emerging company focused on the development and commercialization of new medical technologies and products. The company has a unique technology platform, a wide range of products and services, and a dedicated team of professionals. It strives to ensure high quality and scientific excellence in all business areas and to become a key player in the healthcare industry. VG Life Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating VG Life Sciences's Shares Outstanding

VG Life Sciences's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in VG Life Sciences’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding VG Life Sciences’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in VG Life Sciences’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about VG Life Sciences stock

How many stocks are there of VG Life Sciences?

The current number of stocks of VG Life Sciences is 27.63 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of VG Life Sciences are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of VG Life Sciences evolved in recent years?

The number of shares of VG Life Sciences has increased by 237.41% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. VG Life Sciences as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of VG Life Sciences?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does VG Life Sciences pay?

Over the past 12 months, VG Life Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, VG Life Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of VG Life Sciences?

The current dividend yield of VG Life Sciences is .

When does VG Life Sciences pay dividends?

VG Life Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of VG Life Sciences?

VG Life Sciences paid dividends every year for the past 0 years.

What is the dividend of VG Life Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is VG Life Sciences located?

VG Life Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von VG Life Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of VG Life Sciences from 9/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/30/2024.

When did VG Life Sciences pay the last dividend?

The last dividend was paid out on 9/30/2024.

What was the dividend of VG Life Sciences in the year 2023?

In the year 2023, VG Life Sciences distributed 0 USD as dividends.

In which currency does VG Life Sciences pay out the dividend?

The dividends of VG Life Sciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von VG Life Sciences

Our stock analysis for VG Life Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of VG Life Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.